Phase 2 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- People diagnosed with multiple myeloma or plasmacytoma (types of blood/bone marrow cancer)
- People whose treatment goal is achieving a strictly complete remission (meaning all signs of cancer are gone by very thorough testing)
- People whose doctors expect them to live for more than 12 weeks
- People who have previously had a stem cell transplant using their own stem cells (an "auto-SCT"), regardless of what other treatments they have had before
- People who have suitable veins for a blood-filtering procedure called apheresis, and no medical reasons that would prevent this procedure
- People who are willing to give informed consent and commit to ongoing follow-up appointments
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People with an active infection that is not currently under control
- People with an active HIV, hepatitis B, or hepatitis C infection
- People currently taking steroid medications in tablet or injection form (note: inhaled steroids, such as those used for asthma, do not appear to be a barrier)
- People with other medical conditions that doctors determine would prevent safe participation in the trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients with treatment related adverse effects
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.